Publications – Life Sciences and Healthcare

zh cs fr de it ja ko ru es UA

Life Sciences and Healthcare

What we do > Sectors > Life Sciences and... > Publications

Publications

Telemedicine: A global approach to trends and practices, IBA Healthcare and Life Sciences Law Committee, December 2022

Drug & Medical Device Litigation 2025

Drug & Medical Device Litigation 2025

The latest title in the International Comparative Legal Guide series has now been released, this time devoted to drugs and medical devices. Experts from our firm authored the chapter on Poland.

AI in medical devices

AI in medical devices

How to approach the regulatory “octopus” entangling any new medtech product? Instead of just citing the regulations, we decided to share a hypothetical case study. We answer more than 30 questions from four key areas, but surely this does not exhaust the potential legal issues in this area.

Pharmaceutical Package

Pharmaceutical Package

We examine the planned reform of EU pharmaceutical law—the biggest in 20 years. How will the new regulations affect innovation and access to affordable medicines? Will they reduce the environmental impact of pharmaceutical production?

Investing in Healthcare & Life Sciences

Investing in Healthcare & Life Sciences

The new edition of the annual publication Investing in Healthcare & Life Sciences has now been released. At the invitation of McDermott Will & Emery, publishers of the guide, Joanna Krakowiak drafted the chapter on the regulatory environment for the healthcare sector in Poland.

Pharmaceutical Advertising 2023

Pharmaceutical Advertising 2023

The 20th edition of the International Comparative Legal Guide to pharmaceutical advertising has now been published. Experts from our firm wrote the chapter on Poland.

Legal framework for clinical trials in Poland

Legal framework for clinical trials in Poland

How to conduct clinical trials in Poland - in questions and aswers.